1상모집 중단 (진행 중)

Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults

연구 개요

This clinical research trial will evaluate the safety and tolerability of an experimental drug, ALN-F1202, in healthy participants. The purpose of this trial is to learn about how safe and tolerable the experimental drug is. The trial is looking at several other research questions, including: * What side effects may happen from taking the experimental drug? * How much experimental drug is in the blood at different times? * Whether the body makes antibodies against the experimental drug (which could make the drug less effective or could lead to side effects). * What is the best dose of the experimental drug?

스폰서
리드: 리제네론
적응증
Healthy Volunteer
중재
ALN-F1202, Matching Placebo
목표 등록
56
시작일
2025-03-06
완료(예정)
2026-07-30

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.